We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan
· Delayed Price · Currency is TWD 30.85
-0.85 (-2.68%)
Mar 9, 2026, 1:05 PM CST
We Can Medicines Market Cap
We Can Medicines has a market cap or net worth of 1.43 billion as of March 9, 2026. Its market cap has decreased by -16.98% in one year.
Market Cap
1.43B
Enterprise Value
2.38B
Revenue
3.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.85
Market Cap Chart
Since December 9, 2022, We Can Medicines's market cap has decreased from 1.84B to 1.43B, a decrease of -22.49%. That is a compound annual growth rate of -7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.43B | -7.85% |
| Dec 31, 2025 | 1.55B | -10.72% |
| Dec 31, 2024 | 1.73B | -59.87% |
| Dec 29, 2023 | 4.32B | 13.80% |
| Dec 30, 2022 | 3.80B | 106.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DaBomb Protein Biotech | 1.30B |
| Jia Jie Biomedical | 1.58B |
| Lian Fa International Dining Business | 1.87B |
| Tai Roun Products | 2.28B |
| Wonder Pets Enterprises | 2.35B |
| Hantech Bio-Technology | 2.64B |
| Ten Ren Tea | 2.93B |
| SunWay Biotech Co., LTD. | 3.18B |